wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38672008-FB5FB01C-EE1D-4F99-BAB7-4D0E85E48709
Q38672008-FB5FB01C-EE1D-4F99-BAB7-4D0E85E48709
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38672008-FB5FB01C-EE1D-4F99-BAB7-4D0E85E48709
An economic analysis of high-dose imatinib, dasatinib, and nilotinib for imatinib-resistant chronic phase chronic myeloid leukemia in China: A CHEERS-compliant article.
P2860
Q38672008-FB5FB01C-EE1D-4F99-BAB7-4D0E85E48709
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38672008-FB5FB01C-EE1D-4F99-BAB7-4D0E85E48709
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
568db21fcacb0aca96c3f2c83b8907dc8b1787e9
P2860
Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy.